About NFlection Therapeutics
NFlection Therapeutics is a private company based in Boston, Massachusetts. It has reported $44,000,000 raised in three offerings on Form D since January 2017.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 7, 2023 | Jul 21, 2023 | $4,000,000fully sold | 2 | $2.0M | Debt, OptionsRule 506(b) | Form D ↗ |
| Jun 7, 2022 | Jun 10, 2022amended Jun 21, 2022 | $20,000,000of $30.0M target | 2 | $10.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 30, 2016 | Jan 17, 2017amended Apr 24, 2020 | $20,000,000of $24.0M target | 2 | $10.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $44,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NFlection Therapeutics's Form D filed Jul 21, 2023.
KP
Ketan Patel
Director
CP
Christopher Powala
Director
WH
William Hodder
President and Director
CG
Corey Goodman
Director
JG
Josh Grass
Director
Earlier filings also listed Mark de Souza (executive officer and director, last listed Apr 2020).